BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 28394227)

  • 1. Ribosomal P antibody: 30 years on the road.
    Viana VT; Durcan L; Bonfa E; Elkon KB
    Lupus; 2017 Apr; 26(5):453-462. PubMed ID: 28394227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical relevance of antibodies to ribosomal-P common epitope in two targeted systemic lupus erythematosus populations: a large cohort of consecutive patients and patients with active central nervous system disease.
    Tzioufas AG; Tzortzakis NG; Panou-Pomonis E; Boki KA; Sakarellos-Daitsiotis M; Sakarellos C; Moutsopoulos HM
    Ann Rheum Dis; 2000 Feb; 59(2):99-104. PubMed ID: 10666163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and epitope recognition of anti-ribosome P antibodies from humans with systemic lupus erythematosus and MRL/lpr mice are similar.
    Bonfa E; Marshak-Rothstein A; Weissbach H; Brot N; Elkon K
    J Immunol; 1988 May; 140(10):3434-7. PubMed ID: 2452189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the human autoimmune response to the major C-terminal epitope of the ribosomal P proteins.
    Mahler M; Kessenbrock K; Raats J; Williams R; Fritzler MJ; Blüthner M
    J Mol Med (Berl); 2003 Mar; 81(3):194-204. PubMed ID: 12682728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentric prevalence study of anti P ribosomal autoantibodies in juvenile onset systemic lupus erythematosus compared with adult onset systemic lupus erythematosus.
    Pisoni CN; Muñoz SA; Carrizo C; Cosatti M; Álvarez A; Dubinsky D; Bresan E; Russo R; Borgia E; García M; Sansinanea P; Basta MC; D'Amico MA; Barreira JC; Lancioni E; Soriano E; Cunto Cd; Beron A; Eimon A
    Reumatol Clin; 2015; 11(2):73-7. PubMed ID: 24816340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of antibodies against the native ribosomal P protein complex and recombinant P0, P1, and P2 proteins in the diagnosis of Chinese patients with systemic lupus erythematosus.
    Li J; Shen Y; He J; Jia R; Wang X; Chen X; Wang D; Han L; Zhu L; Chi X; Saschenbrecker S; Dähnrich C; Stöcker W; Schlumberger W; Li ZG
    J Clin Lab Anal; 2013 Mar; 27(2):87-95. PubMed ID: 23400861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major immunoreactive domains of human ribosomal P proteins lie N-terminal to a homologous C-22 sequence: application to a novel ELISA for systemic lupus erythematosus.
    Lin JL; Dubljevic V; Fritzler MJ; Toh BH
    Clin Exp Immunol; 2005 Jul; 141(1):155-64. PubMed ID: 15958082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Central nervous system function in systemic lupus erythematosus.
    Elkon K; Weissbach H; Brot N
    Neurochem Res; 1990 Apr; 15(4):401-6. PubMed ID: 1697040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological biomarkers in neuropsychiatric systemic lupus erythematosus: a comparative cross-sectional study from a tertiary care center in South India.
    Seth G; Sundaresh A; Mariaselvam CM; Kumar G; Chengappa KG; Adarsh MB; Tamouza R; Negi VS
    Lupus; 2020 Apr; 29(4):413-420. PubMed ID: 32106787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropsychiatric manifestations in patients with systemic lupus erythematosus: diagnostic and predictive value of longitudinal examination of anti-ribosomal P antibody.
    Watanabe T; Sato T; Uchiumi T; Arakawa M
    Lupus; 1996 Jun; 5(3):178-83. PubMed ID: 8803887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic value and clinical laboratory associations of antibodies against recombinant ribosomal P0, P1 and P2 proteins and their native heterocomplex in a Caucasian cohort with systemic lupus erythematosus.
    Barkhudarova F; Dähnrich C; Rosemann A; Schneider U; Stöcker W; Burmester GR; Egerer K; Schlumberger W; Hiepe F; Biesen R
    Arthritis Res Ther; 2011 Feb; 13(1):R20. PubMed ID: 21310064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus.
    Hoffman IE; Lauwerys BR; De Keyser F; Huizinga TW; Isenberg D; Cebecauer L; Dehoorne J; Joos R; Hendrickx G; Houssiau F; Elewaut D
    Ann Rheum Dis; 2009 Mar; 68(3):412-5. PubMed ID: 18930995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies in neuropsychiatric lupus.
    Greenwood DL; Gitlits VM; Alderuccio F; Sentry JW; Toh BH
    Autoimmunity; 2002 Mar; 35(2):79-86. PubMed ID: 12071439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients.
    Gerli R; Caponi L; Tincani A; Scorza R; Sabbadini MG; Danieli MG; De Angelis V; Cesarotti M; Piccirilli M; Quartesan R; Moretti P; Cantoni C; Franceschini F; Cavazzana I; Origgi L; Vanoli M; Bozzolo E; Ferrario L; Padovani A; Gambini O; Vanzulli L; Croce D; Bombardieri S
    Rheumatology (Oxford); 2002 Dec; 41(12):1357-66. PubMed ID: 12468814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-ribosomal P protein antibodies.
    Gerli R; Caponi L
    Autoimmunity; 2005 Feb; 38(1):85-92. PubMed ID: 15804709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations.
    Magalhães MB; da Silva LM; Voltarelli JC; Donadi EA; Louzada-Junior P
    Scand J Rheumatol; 2007; 36(6):442-7. PubMed ID: 18092265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single anti-P ribosomal antibodies are not associated with lupus nephritis in patients suffering from active systemic lupus erythematosus.
    Quintana G; Coral-Alvarado P; Aroca G; Patarroyo PM; Chalem P; Iglesias-Gamarra A; Ruiz AI; Cervera R
    Autoimmun Rev; 2010 Sep; 9(11):750-5. PubMed ID: 20601199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies directed against the ribosomal P proteins are not only directed against a common epitope of the P0, P1 and P2 proteins.
    Fabien N; Moreira A; Lavergne JP; Desbos A; Surgey P; Alves de Olivera C; Gonzalo P; Venot A; Bienvenu J; Perrier H; Reboud JP; Monier JC
    J Autoimmun; 1999 Aug; 13(1):103-10. PubMed ID: 10441174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus.
    Choi MY; FitzPatrick RD; Buhler K; Mahler M; Fritzler MJ
    Autoimmun Rev; 2020 Mar; 19(3):102463. PubMed ID: 31927088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.